In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
about
Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.Melanized fungi in human diseaseInfections caused by Scedosporium spp.Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinumIn Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahiiImpact of multidrug-resistant organisms on patients considered for lung transplantation.Infection with Scedosporium apiospermum and S. prolificans, Australia.Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus.In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.Epidemiology of invasive fungal infections in the mediterranean areaIn vitro interaction between fluconazole and triclosan against clinical isolates of fluconazole-resistant Candida albicans determined by different methods.In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.Scedosporium species infections and treatments.Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.Combination treatment of invasive fungal infections.In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.Voriconazole: review of a broad spectrum triazole antifungal agent.Screening the Pathogen Box for Identification of Candida albicans Biofilm InhibitorsTherapy of infections caused by dematiaceous fungi.A combination approach to treating fungal infections.In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole.In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methodsIn vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreusIn vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.Dematiaceous fungi.Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient.Emerging fungal infections in solid organ transplant recipients.Drug combinations against Mucor irregularis in vitro.Use of terbinafine in rare and refractory mycoses.Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazoleIn vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicansSafety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection.Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.Scedosporium prolificans: an emerging pathogen in France?Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma.In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.Terbinafine: a pharmacological and clinical review.
P2860
Q24538756-CEC50971-3623-4105-8C30-3F34161E542DQ24633163-6C175A02-D755-464B-9282-35343B0C5B32Q24657691-0B4F4A55-B0EC-4BA1-BB37-2EB30B1BE964Q28478890-7CA1F3DE-E001-41D9-A7AA-84F9521CDCBEQ28550113-9DAC696C-65DC-444F-B25E-F5CF1D3A4B18Q33576059-D0D25017-6F5A-4CF6-9099-CAD35F3E310CQ33686144-9492D9A9-0EBD-4D6A-9798-093FEE5E8297Q33770230-0A9EA77E-E327-4E3D-B910-26FC307AB4E3Q33938075-E08065D7-DEF0-4C3B-B83E-DAEE6C9CBB91Q34596443-A3538BA6-11B2-417E-9CDB-D551308406DAQ35010686-650C28D2-03F3-4948-8950-8E1030E89EDCQ35065885-54B70409-B94E-4EE6-A744-75DA9EC17EE9Q35152853-AAB22448-568D-4237-BD58-F568F73D34B6Q35622016-ED39672D-8D21-4D48-B443-0A4215AF3528Q35840760-110FCD2F-4C66-466D-BAB9-F905AB637643Q36011378-BB8EF57A-1DBC-4759-B19F-804B6EB2A1EDQ36018571-A7E115FE-9F5B-4715-9140-D4EE05033F48Q36164008-20584473-AB4C-4D2B-B260-86E7A48F7C21Q36177985-DB9DA529-D1D8-4BF3-8ECF-B9958BC0EF0EQ36233517-60D9718C-6C8A-420C-B661-A772D5430330Q36305684-0ED4F1C1-14D5-4D69-964C-C702596445E8Q36314153-4AC841C8-964E-434C-A3E9-E17D91AC8525Q36330214-834FB99B-5645-4B6A-9EEC-C6B87EAB5941Q36425093-E09A04F3-A53C-432F-A5A8-D043BEF79478Q36492208-114F1032-CB1D-4297-A4D7-D85EDDE85B8DQ36667135-1AAC1606-E8EC-4DBA-8A3B-C52D60D791C6Q36738130-5299DE8E-5F65-4465-BE06-F59DC3004943Q36788595-6FBDD867-4B07-4B81-998E-B5F05BD743ECQ36949523-B4DE719A-85C2-4A20-BDA3-7F43768F6425Q36969929-46C141E9-C246-4C07-B7A7-FFE9E1F8E75DQ37071133-0DB2BB4E-4343-4784-ADDE-D414AEBE46FCQ37119654-00545410-EE2F-4AE6-83C9-F01D7C09DF93Q37144780-FC822E54-6F1C-4120-8170-B412C509BC78Q37253708-6200BC9E-23BF-48A3-B24F-389918A05EF2Q37334205-82E1C791-CA69-47E3-B779-884AD98AB93CQ37351705-D4C21FAF-9457-4F41-9031-A7E053CC5996Q37454259-EB2166D7-D77B-4224-A29E-BD8300E3DEBBQ37489291-47E09E50-0D90-4368-9921-89F86F2DB05AQ37499358-B07CA717-75C4-4030-B022-A73BA00FD91CQ37623829-4CDD0E46-AC96-4E41-941B-0720BEED5566
P2860
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
In vitro drug interaction mode ...... osporium prolificans isolates.
@en
In vitro drug interaction mode ...... osporium prolificans isolates.
@nl
type
label
In vitro drug interaction mode ...... osporium prolificans isolates.
@en
In vitro drug interaction mode ...... osporium prolificans isolates.
@nl
prefLabel
In vitro drug interaction mode ...... osporium prolificans isolates.
@en
In vitro drug interaction mode ...... osporium prolificans isolates.
@nl
P2093
P2860
P1476
In vitro drug interaction mode ...... osporium prolificans isolates.
@en
P2093
Jacques F G M Meis
Johan W Mouton
Joseph Meletiadis
Paul E Verweij
P2860
P304
P356
10.1128/AAC.47.1.106-117.2003
P407
P577
2003-01-01T00:00:00Z